Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in the delivery of psychedelic therapies, announced today that it now plans to release financial results for its fiscal 2023 second quarter for the three-month period ended September 30, 2022, after market close on Tuesday, November 29, 2022.
The Company will conduct a conference call and webcast to discuss its results the following morning, Wednesday, November 30, 2022 at 8:30 a.m. ET. The Company moved the call in order to accommodate investors following the Thanksgiving holiday in the U.S.
To access the call, please dial 1-877-407-9716 (within the U.S.) or 1-201-493-6779 (outside the U.S.) and provide conference ID 13734182. A live webcast of the conference call can be accessed via the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website here.
For those unable to attend the live call, a telephonic replay will be available until 11:59 p.m. ET on Wednesday, December 14, 2022. To access the replay dial 1-844-512-2921 (within the U.S.) or 1-412-317-6671 (outside the U.S.) and provide conference ID 13734182. The webcast will be archived and available in the Events and Presentations section of the Field Trip Health & Wellness Investor Relations website approximately one hour after the conclusion of the live call.
About Field Trip Health & Wellness Ltd
With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.